Press Room

DPI China 2024

Start
Thursday, March 21, 2024
End
Thursday, March 21, 2024
Location: Hangzhou, China
DPI China_2024_Hovione

Looking for a complete One-Site Solution for your inhalation and nasal therapies? Meet Hovione at the 11st DPI China Technology Conference! Delivering solutions every breath of the way.

We live and breathe innovation for the successful delivery of your inhalation and nasal therapies.

Hovione offers customized high-performance APIs, particle engineering and formulation along with a full range of highly specialized, patented and innovative devices, all in one site.

Don’t miss the chance to speak with our Inhalation Experts. 

On March 21, our team is at the 11th DPI China Technology Conference ready to share how this integration on a single site can support your project.

ORAL PRESENTATION – March 21

"End-to-end Respiratory Drug Delivery Platforms", with João Ventura, Product Management Director, Business Management Products.

The presentation will provide a perspective on the status and outlook of respiratory drug delivery and address the most relevant platforms for end-to-end dry powder inhalation (DPI) development, as DPIs are the dosage form of choice for achieving superior delivery efficiency to patients.

This presentation will focus on advanced particle engineering technologies for manufacturing inhalation active pharmaceutical ingredients (APIs), new formulation development platforms, aiming to address the pharmacokinetics requirements of the target drug and indication, and device developments for maximum drug delivery efficiency for lung delivery. An integrated, end-to-end development approach will be presented designed to maximize drug delivery efficiency and safety and address a diversified array of diseases.

 

Schedule a meeting today.

Learn more about our Inhalation and Nasal offering.

 

 

Also in the Press Room

See All

In an interview with Executiva, a portuguese media outlet focused on women´s leadership, Diane Villax, co-founder and long-standing leader of Hovione, reflects on her journey and the company’s development over more than six decades. Diane Villax’s career began at a time when few women worked outside the home. At 19, she joined a trading company as a foreign languages correspondent, where she developed essential business skills — including commercial correspondence, banking and export procedures — that later proved instrumental in helping her husband, Ivan Villax, establish Hovione in 1959. From its earliest days operating in the family home in Lisbon, Hovione adopted an international outlook. The company’s first major customers were in Japan, setting demanding quality standards that helped shape its long-term position in global markets. Over the following decades, Hovione expanded its footprint with the construction of its first manufacturing site in Loures (1969), followed by expansion to Macau (1986), the United States (New Jersey, early 2000s) and Ireland (Cork). The company grew into a global organization with more than 2,500 employees — including over 300 scientists — and a reputation as a preferred supplier to leading pharmaceutical companies worldwide. Throughout the interview, Diane highlights the values that have guided the company’s development: a commitment to excellence, a strong work ethic, and a focus on quality and long-term relationships. Although she did not have formal business training, she learned “on the job” and brought discipline, precision and structure to her role — particularly in the company’s early financial and administrative leadership. Now in her nineties and an active member of Hovione’s Board of Directors, Diane Villax remains engaged with the company’s evolution and governance, reflecting a continued commitment to its long-term development. Her story reflects entrepreneurial drive, resilience and long-term leadership — and offers insight into the values that have shaped Hovione’s trajectory for more than six decades. Read the full interview at Executiva.pt (in portuguese).    

Article

Hovione’s Diane Villax: “I was not brought up to be a business woman”

Feb 23, 2026